Focalin vs. Intuniv

See how Focalin and Intuniv compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Focalin is a fast-acting stimulant taken twice daily, while Intuniv is a non-stimulant taken once a day that works more gradually.

  • Focalin carries a boxed warning for abuse and dependence as a Schedule II drug, while Intuniv has no known abuse potential but commonly causes sedation and low blood pressure.

  • Focalin is FDA-approved for ADHD in both adults and children, while Intuniv is only FDA-approved for children and teens ages 6 to 17.

Focalin vs. Intuniv Drug Summary

Focalin

Focalin (dexmethylphenidate) is a CNS stimulant that treats ADHD by increasing dopamine and norepinephrine activity in the brain. It's an immediate-release tablet taken twice daily, at least four hours apart, and is FDA-approved for adults and children ages 6 and up.

Intuniv

Intuniv (guanfacine) is a non-stimulant alpha2A-adrenergic agonist that treats ADHD by calming overactive signaling in the prefrontal cortex. It's an extended-release tablet taken once daily, alone or alongside a stimulant, and is FDA-approved for children and teens ages 6 to 17.

Focalin vs. Intuniv Side Effects

Focalin

Most common
abdominal pain (up to 5%)
fever (up to 5%)
anorexia (up to 5%)
nausea (up to 5%)

Intuniv

Most common
somnolence (up to 38%)
headache (up to 24%)
fatigue (up to 14%)
abdominal pain (up to 11%)

Focalin vs. Intuniv Dosage

Focalin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2.5 mg twice daily At the start
Maximum dose 10 mg twice daily If needed
Dose changes 2 increases As tolerated

Intuniv

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily Week 1
Maximum dose 4 mg once daily Week 4 onward
Dose changes 3 increases Every week

Focalin vs. Intuniv Indications

Focalin

Focalin is approved to treat ADHD in children ages 6 and older, teens, and adults, either alone or as part of a broader treatment plan. It works quickly to improve focus and reduce hyperactivity and impulsivity, often within about an hour of dosing.

  • ADHD in children ages 6 and older

  • ADHD in adolescents

  • ADHD in adults

  • Used as part of a total treatment program including therapy or behavioral support

Intuniv

Intuniv is approved to treat ADHD in children and adolescents ages 6 to 17, either on its own or added to a stimulant for extra symptom control. Doctors sometimes prescribe it off-label for adults with ADHD, though it hasn't been studied in that age group.

  • ADHD monotherapy in children and adolescents 6-17

  • Add-on therapy to stimulant medications in children and adolescents 6-17

  • Off-label use in adults with ADHD

  • Used when stimulant side effects or abuse risk are a concern

Focalin vs. Intuniv Pros and Cons

Focalin

Focalin has decades of clinical use as a stimulant and tends to act faster than non-stimulant options like Intuniv. As a Schedule II controlled substance, it carries a higher risk of misuse and requires stricter prescription monitoring.

Pros

  • Works within about an hour of taking it

  • Lower milligram doses needed than standard methylphenidate

  • Also FDA-approved for adults with ADHD

  • Roughly $60 to $150 per month before insurance, versus $290 to $370 for Intuniv

Cons

  • Schedule II controlled substance with abuse and dependence risk

  • Requires twice-daily dosing at least 4 hours apart

  • Cannot be combined with MAOIs due to hypertensive crisis risk

  • Common side effects include appetite loss, insomnia, and nervousness

Intuniv

Intuniv is a non-stimulant, so it carries no abuse risk and can be combined with a stimulant for added symptom control. Its main trade-off is a higher rate of sedation and the need for gradual dosing changes to protect blood pressure.

Pros

  • No known abuse or dependence potential

  • Once-daily dosing, morning or evening

  • Can be added to a stimulant instead of switching medications

  • No restrictions around MAOIs like Focalin has

Cons

  • Sedation and fatigue are common, up to 38%

  • Requires blood pressure monitoring during treatment

  • Must be tapered off gradually to avoid rebound hypertension

  • Not FDA-approved for adults, only for ages 6 to 17

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.